Clinical trial of long term efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHD

Trial Profile

Clinical trial of long term efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHD

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Dec 2016

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Systemic scleroderma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 21 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top